Clinical Characteristics All All SCS SCS Non-SCS Non-SCS
n % n % n % p-value
N 71 100.0 52 73.2 19 26.8
Median age (Range), years 48(26-69) 48(26-69) 45.5(26-65) 45.5(26-65) 55(44-69) 55(44-69)
Age at diagnosis (y) 0.017
<50 39 54.9 33 63.5 6 31.6
≥50 32 45.1 19 36.5 13 68.4
Parity 0.198
0 4 5.9 4 8.2 0 0.0
1 41 60.3 31 63.3 10 52.6
>1 23 33.8 14 28.6 9 47.4
BMI 0.400
<24 39 54.9 27 51.9 12 63.2
≥24 32 45.1 25 48.1 7 36.8
Pathologic Stage (FIGO 2009) Pathologic Stage (FIGO 2009) Pathologic Stage (FIGO 2009) 0.027
I 55 77.5 45 86.5 10 52.6
II 8 11.3 3 5.8 5 26.3
III 3 4.2 2 3.8 1 5.3
IV 5 7.0 2 3.8 3 15.8
Surgical route of primary surgery Surgical route of primary surgery Surgical route of primary surgery 0.002
Hysterectomy 51 71.8 33 63.5 18 94.7
Myomectomy 17 23.9 17 32.7 0 0.0
Radical hysterectomy 3 4.2 2 3.8 1 5.3
Initial adjuvant chemotherapy Initial adjuvant chemotherapy Initial adjuvant chemotherapy 0.100
Yes 45 63.4 30 57.7 15 78.9
No 26 36.6 22 42.3 4 21.1
Initial adjuvant radiotherapy Initial adjuvant radiotherapy Initial adjuvant radiotherapy 0.613
Yes 3 4.2 2 3.8 1 5.3
No 68 95.8 50 96.2 18 94.7
Time to fist recurrence Time to fist recurrence Time to fist recurrence 0.043
≥12 months 47 66.2 38 73.1 9 47.4
<12 months 24 33.8 14 26.9 10 52.6
Isolated site* 0.009
Yes 20 28.2 19 36.5 1 5.3
No 51 71.8 33 63.5 18 94.7
Multiple locations# 0.015
Yes 18 25.4 9 17.3 9 47.4
No 53 74.6 43 82.7 10 52.6